IL6 and congenital rubella syndrome: Dexamethasone (10 mg q6h, IV) and methylprednisolone (1 mg/kg q12h, IV) were administered to treat ICANS without concurrent CRS or ICANS with concurrent CRS that did not respond to anti-IL-6 therapy.